Koninklijke Philips stock has recovered on a 1 year view but, after a 5 year decline in total return, the current valuation signals suggest the shares now sit in a middle ground rather than as an obvious bargain or clear excess. Over 5 years, shareholders are down 29.7% in total return, which raises the bar for judging whether the recent rebound is enough to justify staying invested at current levels. New product launches such as the Alturion ultrasound system and partnerships like the...

Senzime AB (SNZZF) reports improved financial metrics and a pivotal partnership with Philips, despite facing headwinds in the US market.

Senzime AB (SNZZF) reports a 90% growth, strategic US contracts, and aims for positive cash flow by 2026 amidst operational challenges.